Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
OHE Presents at Two Key Workshops on Use of EQ-5D in HTA Across Asia
27 March 2013
OHE’s Prof Nancy Devlin presented at two key workshops held for researchers and HTA policy makers from across Asia. The workshops were organised by Prof Nan…
Review of Plans for Refining Patient-Reported Outcomes Measures
19 February 2013
At a recent meeting of the Pharmaceutical Onology Initiative’s (POI) HTA group, OHE’s Nancy Devlin provided an overview of the EuroQol Group’s scientific research agenda for…
EQ-5D Index Clustering: Causes and Implications for Health Care
5 February 2013
In a paper presented at the January 2013 Health Economics Study Group meeting, David Parkin of the NHS and OHE’s Nancy Devlin and Yan Feng examined…
New OHE Study Compares Decisions by Five HTA Agencies on Oncology Meds
31 January 2013
Just out in the International Journal of Technology Assessment in Health Care is an important new study that reviews appraisals of breast cancer and colorectal cancer…
Overview of the OHE Study on the Cost of Drug Development Presented
29 January 2013
OHE’s Jorge Mestre-Ferrandiz reviewed the results of OHE’s recent study on the R&D cost of developing a new drug at a seminar at University College London.…
Changes in Determining Medicines Pricing in France, Germany and the UK
24 January 2013
New requirements for health technology assessment in Europe have important implications for markets and for access to new medicines. At a recent conference, OHE’s Jorge Mestre-Ferrandiz…
New Pilot Study: Capturing Public Preferences about Health Care Priorities
16 January 2013
The proposals from the UK Department of Health (DH) for value based pricing (VBP) include a process whereby higher prices would be granted to medicines that…
The Influence of Cost-effectiveness and Other Factors on NICE Decisions
1 November 2013
In this Research Paper, the authors explore which factors have most influenced NICE decisions from 1999 through the end of 2011. The research has two objectives:…
Spotlight on OHE: Making Health Care Choices and Decisions
7 January 2013
OHE’s research and consulting captures a range of key issues that affect how health care systems are organised and how decisions are made within them. For…